JO
PRCT icon

John Overdeck’s Procept Biorobotics PRCT Stock Holding History

John Overdeck’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$384K Buy
+17,000
New +$426K ﹤0.01% 4354

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

John Overdeck's PRCT Position: Q2 2026 in Review

John Overdeck reduced its Procept Biorobotics (PRCT) stake by 78% in Q2 2026, selling an estimated $4.44M and leaving 51,003 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #3498.

John Overdeck first reported a position in PRCT in Q4 2021 and has held it in 13 quarters since. The position peaked at $28.5M in Q4 2024. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • John Overdeck held 51,003 shares of Procept Biorobotics worth $1.15M as of Q2 2026.
  • John Overdeck sold 177,508 Procept Biorobotics shares in Q2 2026, an estimated $4.44M.
  • Procept Biorobotics made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3498 holding.
  • John Overdeck first reported a position in Procept Biorobotics in Q4 2021 and has held it in 13 quarters since.
  • John Overdeck's Procept Biorobotics position peaked at $28.5M in Q4 2024.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.